Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04704154
Title A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Bayer
Indications

esophagus squamous cell carcinoma

cholangiocarcinoma

anaplastic astrocytoma

intrahepatic cholangiocarcinoma

head and neck squamous cell carcinoma

gallbladder cancer

glioblastoma

malignant astrocytoma

oropharynx cancer

pancreatic ductal adenocarcinoma

Therapies

Nivolumab + Regorafenib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | BEL

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Rocky Mountain Cancer Centers / Aurora, CO Aurora Colorado 80012 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
Baylor Charles A. Sammons Cancer Center at Dallas Dallas Texas 75246 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Hôpital Erasme/Erasmus Ziekenhuis Bruxelles - Brussel 1070 Belgium Details
UZ Antwerpen Edegem 2650 Belgium Details
CHU de Liège Liege 4000 Belgium Details
Institut Bergonié - Unicancer Nouvelle Aquitaine Bordeaux Cedex 33076 France Details
Centre Léon Bérard Lyon Cedex 69008 France Details
Hôpital de la Pitié-Salpétrière Paris 75651 France Details
Institut de Cancérologie de l'Ouest - Saint Herblain Saint Herblain 44805 France Details
Institut Claudius Regaud - iUCT Oncopole Toulouse Cedex 9 31059 France Details
Institut Gustave Roussy Villejuif Cedex 94805 France Details
AUSL di Bologna Bologna Emilia-Romagna 40139 Italy Details
Istituto Clinico Humanitas - Humanitas Mirasole S.p.A. Milano Lombardia 20089 Italy Details
Fondazione IRCCS Istituto Neurologico Carlo Besta Milano Lombardia 20133 Italy Details
ASST Grande Ospedale Metropolitano Niguarda Milano Lombardia 20162 Italy Details
Istituto Oncologico Veneto IRCCS (IOV) Padova Veneto 35128 Italy Details
Aichi Cancer Center Hospital Nagoya Aichi 464-8681 Japan Details
Kobe University Hospital Kobe Hyogo 650-0017 Japan Details
Saitama Cancer Center Kita-Adachigun Saitama 362-0806 Japan Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
The Cancer Institute Hospital of JFCR Koto-ku Tokyo 135-8550 Japan Details
Seoul National University Hospital Seoul Seoul Teugbyeolsi 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
China Medical University Hospital Taichung 40447 Taiwan Details
Chi-Mei Medical Center, Liouyine Tainan Taiwan Details
Taipei Veterans General Hospital Taipei 11217 Taiwan Details
Royal Marsden NHS Trust (Surrey) Sutton Surrey SM2 5PT United Kingdom Details
University Hospitals Coventry and Warwickshire NHS Trust Coventry West Midlands CV2 2DX United Kingdom Details
Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
Royal Marsden Hospital (London) London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field